Genetiske variationers betydning for effekten af selektive serotoningenoptagelseshaemmere

Jens O Drachmann Bukh, Camilla Bock, Niels Peter Ole Mors, Lars Vedel Kessing

Abstract

The outcome of psychopharmacological treatment may depend on genetic polymorphisms of various neurotransmitter systems. We summarize studies of associations between genetic variations with relation to the serotonin system and response to selective serotonin reuptake inhibitors. The results are still preliminary but suggest that treatment response to antidepressant drugs is influenced by genetic factors. They also indicate that the genetic component is polygenic and highly complex and might manifest itself in interaction with other biological and environmental factors.

Bidragets oversatte titelThe influence of genetic variations on the effect of selective serotonin reuptake inhibitors
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind169
Udgave nummer16
Sider (fra-til)1439-41
Antal sider3
ISSN0041-5782
StatusUdgivet - 16 apr. 2007

Emneord

  • Antidepressive Agents, Second-Generation
  • Depression
  • Depressive Disorder
  • Humans
  • Pharmacogenetics
  • Polymorphism, Genetic
  • Receptors, Serotonin
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Treatment Outcome

Fingeraftryk

Dyk ned i forskningsemnerne om 'Genetiske variationers betydning for effekten af selektive serotoningenoptagelseshaemmere'. Sammen danner de et unikt fingeraftryk.

Citationsformater